Appointments
Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and...
Dr Nick Johnson has been appointed the Chief Strategy and Impact Officer of the Cell and Gene Therapy Catapult.
Johnson was previously the...
German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year history, promoting...
Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up the mantle of the...
Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to the role....
MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.
Fattaey has over 20 years experience in the industry. His...
FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has emerged.
Dr Carter...
Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect at the...
Nordic Nanovector has announced that Dr Christine Wilkinson Blanc has been appointed as the Chief Medical Officer of the company.
Blanc has...
Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and he will...